Diagnosis and new treatments in genetic neuropathies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2009-11-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2008.158295PMID 19917815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment

  2009cited by this paper
• Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2

  2008influential reference
• Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations.

  2008cited by this paper
• Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.

  2008cited by this paper
• A central role for Necl4 (SynCAM4) in Schwann cell–axon interaction and myelination

  2007cited by this paper
• Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease

  2007cited by this paper
• Molecular genetics of X-linked Charcot-Marie-Tooth disease

  2007cited by this paper
• Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies

  2007cited by this paper
• Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease

  2007cited by this paper
• CMT1X phenotypes represent loss of GJB1 gene function

  2007cited by this paper
• Therapeutic strategies for the inherited neuropathies

  2007cited by this paper
• Nectin-like proteins mediate axon–Schwann cell interactions along the internode and are essential for myelination

  2007cited by this paper
• Autosomal‐recessive and X‐linked forms of hereditary motor and sensory neuropathy in childhood

  2007cited by this paper
• Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease

  2007influential reference
• Sorting out the inherited neuropathies.

  2007cited by this paper
• Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome.

  2007cited by this paper
• Potential Role of Tubulin Acetylation and Microtubule‐Based Protein Trafficking in Familial Dysautonomia

  2007cited by this paper
• CMT 1 X phenotypes represent loss of GJB 1 gene function

  2007cited by this paper
• Unraveling the genetics of distal hereditary motor neuronopathies

  2007cited by this paper
• Altered Axonal Mitochondrial Transport in the Pathogenesis of Charcot-Marie-Tooth Disease from Mitofusin 2 Mutations

  2007cited by this paper
• Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease

  2007cited by this paper
• Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I).

  2006cited by this paper
• Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2

  2006cited by this paper
• Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.

  2006cited by this paper
• 136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands.

  2006cited by this paper
• Faculty Opinions recommendation of Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.

  2006cited by this paper
• An SCN9A channelopathy causes congenital inability to experience pain

  2006cited by this paper
• Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy

  2006cited by this paper
• SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.

  2006cited by this paper
• Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies

  2006cited by this paper
• Molecular mechanism of mitochondrial membrane fusion.

  2006cited by this paper
• Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot‐Marie‐Tooth disease)

  2006influential reference
• Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model

  2005cited by this paper
• Disruption of Fusion Results in Mitochondrial Heterogeneity and Dysfunction*

  2005cited by this paper
• Regulatory role of dynamin‐2 in VEGFR‐2/KDR‐mediated endothelial signaling

  2005cited by this paper
• Emerging pathways for hereditary axonopathies

  2005cited by this paper
• Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease

  2005cited by this paper
• GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria.

  2005cited by this paper
• Neuropathies—Translating Causes into Treatments

  2005cited by this paper
• Autosomal-Recessive Charcot-Marie-Tooth Diseases

  2005cited by this paper
• Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network

  2005cited by this paper
• Emerging functions of mammalian mitochondrial fusion and fission.

  2005cited by this paper
• A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

  2004cited by this paper
• SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve

  2004cited by this paper
• Electrophysiologic Consequences of Myelination

  2004influential reference
• Phenotypic clustering in MPZ mutations.

  2004cited by this paper
• Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A

  2004cited by this paper
• OPA1 requires mitofusin 1 to promote mitochondrial fusion.

  2004cited by this paper
• [Different phenotypes of Charcot-Marie-Tooth disease caused by mutations in the same gene. Are classical criteria for classification still valid?].

  2004cited by this paper
• Myelin Biology and Disorders

  2004influential reference
• Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia

  2004cited by this paper
• Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

  2004cited by this paper
• From Neuroscience to Neurology: Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology

  2004cited by this paper
• Loss‐of‐function phenotype of hereditary neuropathy with liability to pressure palsies

  2004cited by this paper
• DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

  2004cited by this paper
• The Regulation of Pubertal Growth

  2003cited by this paper
• Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

  2003cited by this paper
• Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.

  2003cited by this paper
• Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C

  2003cited by this paper
• The CNS phenotype of X-linked Charcot-Marie-Tooth disease

  2003cited by this paper
• Phenotypic Differences between Peripheral Myelin Protein‐22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot‐Marie‐Tooth‐Related Diseases

  2003cited by this paper
• Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells

  2003cited by this paper
• Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)

  2003cited by this paper
• Back signaling by the Nrg-1 intracellular domain

  2003cited by this paper
• Polarized domains of myelinated axons.

  2003cited by this paper
• Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy.

  2003cited by this paper
• Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review.

  2003cited by this paper
• Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo.

  2002cited by this paper
• The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease.

  2002cited by this paper
• Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21

  2002cited by this paper
• Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.

  2002cited by this paper
• Cellular mechanisms of connexin32 mutations associated with CNS manifestations

  2002cited by this paper
• Transient central nervous system white matter abnormality in X‐linked Charcot‐Marie‐Tooth disease

  2002cited by this paper
• The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease

  2002cited by this paper
• Hereditary neuropathy with liability to pressure palsy

  2002cited by this paper
• Dynamin and clathrin are required for the biogenesis of a distinct class of secretory vesicles in yeast

  2002cited by this paper
• Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia.

  2001cited by this paper
• Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I

  2001cited by this paper
• Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): Mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor

  2001cited by this paper
• SPTLC1 is mutated in hereditary sensory neuropathy, type 1

  2001cited by this paper
• PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.

  2000cited by this paper
• A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

  2000cited by this paper
• Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis.

  2000cited by this paper
• Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2

  2000cited by this paper
• OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28

  2000cited by this paper
• Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.

  2000cited by this paper
• A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis.

  1999cited by this paper
• Transport of Trembler-J Mutant Peripheral Myelin Protein 22 Is Blocked in the Intermediate Compartment and Affects the Transport of the Wild-Type Protein by Direct Interaction

  1999cited by this paper
• Electrodiagnostic Findings in CMTX: A Disorder of the Schwann Cell and Peripheral Nerve Myelin

  1999cited by this paper
• Demyelinating X‐linked Charcot–Marie–Tooth disease: Unusual electrophysiological findings

  1999cited by this paper
• Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33

  1999cited by this paper
• A Novel NTRK 1 Mutation Associated with Congenital Insensitivity to Pain with Anhidrosis

  1999cited by this paper
• Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies

  1998cited by this paper
• Neurons Promote the Translocation of Peripheral Myelin Protein 22 into Myelin

  1997cited by this paper
• A transgenic rat model of Charcot-Marie-Tooth disease.

  1996influential reference
• Neuregulins in development.

  1996cited by this paper
• Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study

  1996cited by this paper
• A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe, de novo Charcot-Marie-Tooth disease

  1996cited by this paper
• Treatment of stable chronic demyelinating polyneuropathy with 3,4-diaminopyridine.

  1995cited by this paper
• Krox-20 controls myelination in the peripheral nervous system

  1994cited by this paper

• Balance Confidence and Falls in Individuals With Charcot–Marie–Tooth Disease: A Cross‐Sectional Observational Study

  2025cites this paper
• Guía práctica de diagnóstico y manejo en la enfermedad de Charcot-Marie-Tooth en España

  2025cites this paper
• Perception of ankle foot orthoses by individuals with Charcot-Marie-Tooth disease.

  2025cites this paper
• Persistent toe walking as a prominent feature in pediatric PMP22- Related neuropathies: A retrospective cohort study

  2025cites this paper
• Phytochemical Profile and Analgesic Properties of Chicory Root Extract in the Hot-Plate Test in Mice

  2025cites this paper
• Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

  2024cites this paper
• Research Toward Understanding the Benefits and Limitations of Orthotic Use To Improve Mobility and Balance for Individuals With Neuropathic Conditions.

  2024cites this paper
• Telecoaching: a potential new training model for Charcot-Marie-Tooth patients: a systematic review

  2024cites this paper
• An Elderly Woman with Complaints of Pain and Hearing Loss, Diagnosed with CMT1A with PMP22 Duplication

  2023cites this paper
• Distinct Phenotypic and microRNA Expression in X-Linked Charcot–Marie–Tooth Correlated with a Novel Mutation in the GJB1 Gene

  2022cites this paper
• Patient-Reported Symptom Burden of Charcot–Marie–Tooth Disease Type 1A: Findings From an Observational Digital Lifestyle Study

  2022cites this paper
• Rubbing Salt in the Wound: Molecular Evolutionary Analysis of Pain-Related Genes Reveals the Pain Adaptation of Cetaceans in Seawater

  2022cites this paper
• Drosophila Models for Charcot–Marie–Tooth Neuropathy Related to Aminoacyl-tRNA Synthetases

  2021cites this paper
• Screening for SH3TC2 variants in Charcot–Marie–Tooth disease in a cohort of Chinese patients

  2021cites this paper
• Inherited Disorders of Human Copper Metabolism

  2021cites this paper
• Effect of 4 Weeks Aerobic Training on Trk-B, PKC and AKT in Hippocampus of Male rats with Alzheimer’s Disease

  2021cites this paper
• Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants

  2021cites this paper
• Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center

  2020cites this paper
• Clinical and neurological characteristic of hereditary sensorimotor neuropathy type 1A

  2020cites this paper
• Genetic mechanisms of peripheral nerve disease.

  2020cites this paper
• A variant of the gene HARS detected in the clinical exome: etiology of a peripheral neuropathy undiagnosed for 20 years

  2020cites this paper
• Paternal gender specificity and mild phenotypes in Charcot–Marie–Tooth type 1A patients with de novo 17p12 rearrangements

  2020cites this paper
• Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases †

  2020cites this paper
• Patient-reported impact of Charcot-Marie-Tooth disease: protocol for a real-world digital lifestyle study.

  2020cites this paper
• The patient-reported impact of Charcot-Marie-Tooth disease in the real world: the design and conduct of a digital lifestyle study (CMT&Me)

  2020cites this paper
• A novel HSPB1 mutation associated with a late onset CMT2 phenotype: Case presentation and systematic review of the literature

  2020cites this paper
• Satisfaction with ankle foot orthoses in individuals with Charcot‐Marie‐Tooth disease

  2020cites this paper
• Variante en gen HARS detectada en exoma clínico: etiología de neuropatía periférica tras más de 20 años sin diagnóstico

  2020cites this paper
• The audiologic profile of patients with Charcot-Marie Tooth neuropathy can be characterised by both cochlear and neural deficits

  2019cites this paper
• Aktuelles zur Charcot-Marie-Tooth-Erkrankung

  2019cites this paper
• Gene Therapy for CMT Inherited Neuropathy

  2019cites this paper
• SuperCLEM: an accessible correlative light and electron microscopy approach for investigation of neurons and glia in vitro

  2019cites this paper
• Painful Peripheral Neuropathies

  2018cites this paper
• The Charcot–Marie–Tooth Health Index: Evaluation of a Patient‐Reported Outcome

  2018cites this paper
• Enhanced axonal Neuregulin-1 type-III signaling ameliorates disease severity in a CMT1B mouse model

  2018cites this paper
• Extreme Ends of Pain Sensitivity in SCN9A Mutation Variants: Case Report and Literature Review.

  2018cites this paper
• Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot–Marie–Tooth type 1B mouse model

  2018cites this paper
• Neuropathy.

  2018cites this paper
• A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland

  2017cites this paper
• AUTOSOMAL RECESSIVE PERIPHERAL NEUROPATHY WITH NEUROMYOTONIA (ARAN-NM): DESCRIPTION OF A CLINICAL CASE CONFIRMED BY A MUTATION IN THE HINT1 GENE

  2017cites this paper
• Peripheral Nerve Neuropathies Including Charcot–Marie–Tooth Disease

  2017cites this paper
• Progressive Motor Weakness in a Somalian Man

  2017cites this paper
• 141 – Genetic Peripheral Neuropathies

  2017cites this paper
• Clinical and genetic spectra of Charcot‐Marie‐Tooth disease in Chinese Han patients

  2017cites this paper
• Dysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease

  2016cites this paper
• Nerve ultrasound in CMT2E/CMT1F due to NEFL mutation: Confirmation of an axonal pathology.

  2016cites this paper
• Mutation Analysis of Gap Junction Protein Beta 1 and Genotype–Phenotype Correlation in X-linked Charcot–Marie–Tooth Disease in Chinese Patients

  2016cites this paper
• Revista Española de Cirugía Ortopédica y Traumatología

  2016cites this paper
• Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience.

  2016cites this paper
• The control of Schwann cell myelination during development and after nerve injury

  2016cites this paper
• Early life programming of pain: focus on neuroimmune to endocrine communication

  2016cites this paper
• Nerve ultrasound in patients with CMT1C: Description of 3 cases

  2015cites this paper
• [Experience in molecular diagnostic in hereditary neuropathies in a pediatric tertiary hospital].

  2015cites this paper
• Hereditary Neuropathies in Late Childhood and Adolescence

  2015cites this paper
• Hereditary peripheral neuropathies diagnosed by next-generation sequencing.

  2015cites this paper
• Chapter 12 – Peripheral Neuropathies

  2015cites this paper
• A novel mutation in GJB1 (c.212T>G) in a Chinese family with X-linked Charcot-Marie-Tooth disease.

  2015cites this paper
• Prospective study of muscle cramps in Charcot‐Marie‐Tooth disease

  2015cites this paper
• Advances in diagnostics and outcome measures in peripheral neuropathies.

  2015cites this paper
• Clinical and genetic spectra in a series of Chinese patients with Charcot-Marie-Tooth disease.

  2015cites this paper
• CAN we say that modern radiologic contrast agents are safe in myasthenia gravis?

  2015cites this paper
• Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective.

  2014cites this paper
• Clinical prospective study on disease variability and score generation in patients with Charcot-Marie- Tooth disease type 1A (HMSN1A)

  2014cites this paper
• Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.

  2014cites this paper
• Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.

  2014cites this paper
• Mutation Analysis of MFN2, GJB1, MPZ and PMP22 in Italian Patients with Axonal Charcot–Marie–Tooth Disease

  2014cites this paper
• Etanercept for Psoriasis and Psoriatic Arthritis in a Patient with Charcot-Marie-Tooth Disease

  2014cites this paper
• A novel RAB7 mutation in a Chinese family with Charcot-Marie-Tooth type 2B disease.

  2014cites this paper
• Experimental Treatment of Acquired and Inherited Neuropathies

  2014influential citation
• Genetic Diagnosis of Charcot-Marie-Tooth Disease in a Population by Next-Generation Sequencing

  2014influential citation
• Defining the anti-apoptotic function of the survival of motor neuron (SMN) protein and assessment of a novel therapy for the treatment of spinal muscular atrophy (SMA)

  2014cites this paper
• Clinical and Molecular Genetic Studies in Mitochondrial Disease

  2014cites this paper
• A Novel RAB7 Mutation in a Chinese Family with Charcot-Marie-Tooth type 2B disease.

  2014cites this paper
• Identifying novel genes and genetic/phenotypic spectra for inherited neurodegenerative disorders using next-generation sequencing

  2014cites this paper
• Genetic testing practices for Charcot–Marie–Tooth type 1A disease

  2014cites this paper
• Priming of inflammatory pain responses by a neonatal immune challenge: implications of neuroimmune-endocrine communication for pain

  2014cites this paper
• Autosomal recessive axonal neuropathy with neuromyotonia: a rare entity.

  2014cites this paper
• Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation.

  2014cites this paper
• Anterior tibialis cmap amplitude correlations with impairment in CMT1A

  2013influential citation
• Charcot-Marie-Tooth syndrome and neurofibromatosis type 1 with multiple neurofibromas of the entire spinal nerve roots

  2013cites this paper
• PLEKHG 5 deficiency leads to an intermediate form of autosomal-recessive Charcot – Marie – Tooth disease

  2013cites this paper
• Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP

  2013cites this paper
• Functional Recovery of Regenerating Motor Axons is Delayed in Mice Heterozygously Deficient for the Myelin Protein P0 Gene

  2013cites this paper
• A novel RAB 7 mutation in a Chinese family with Charcot – Marie – Tooth type 2 B disease

  2013cites this paper
• DNA testing in hereditary neuropathies.

  2013cites this paper
• Inherited peripheral neuropathies.

  2013cites this paper
• Patient Identification of the Symptomatic Impact of Charcot–Marie–Tooth Disease Type 1A

  2013cites this paper
• PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease.

  2013cites this paper
• Inherited neuropathies and deafness caused by a PMP22 point mutation: a case report and a review of the literature

  2013influential citation
• Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditions.

  2013cites this paper
• Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot‐Marie‐Tooth disease

  2013cites this paper
• Inherited Neuropathies

  2012cites this paper
• [Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease].

  2012cites this paper
• Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice.

  2012cites this paper
• Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease

  2012cites this paper
• Survival of Motor Neuron (SMN) protein over-expression prevents calpain mediated cleavage and activation of procaspase-3 in differentiated human SH-SY5Y cells

  2012cites this paper
• Exome sequencing is an efficient tool for genetic screening of Charcot–Marie–Tooth Disease

  2012cites this paper
• Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort

  2012cites this paper
• Clinical and histopathological study of Charcot-Marie-Tooth neuropathy with a novel S90W mutation in BSCL2

  2012cites this paper
• Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing

  2012cites this paper